Clinical proof demand outrages UK supplement makers; CRO goes CDISC;

> U.K. supplement makers and health food manufacturers are angry that regulators are beginning to demand clinical data that supports label claims. Blog | Video

> CRO Max Neeman International now offers CDISC services and modified solutions, including ongoing and legacy clinical data conversion, implementation of CDISC standards and CDISC compliance checks. Release

> Mobile drug reference tool maker Epocrates has named Jake Winebaum, an Internet incubator co-founder, to its board. Release

> Bay Clinic in Hawaii will receive $805,000 in stimulus funding over two years to support information technology improvements including hardware, a data center and enhancements to electronic practice management. Article

> The Patient Recruitment Organization has elected Robert Loll as vice chairman. Release

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.